Activating transcription factor-2 (ATF2) is a key determinant of resistance to endocrine treatment in an in vitro model of breast cancer
- Athina Giannoudis
- , Mohammed Imad Malki
- , Bharath Rudraraju
- , Hisham Mohhamed
- , Suraj Menon
- , Triantafillos Liloglou
- , Simak Ali
- , Jason S Carroll
- , Carlo Palmieri
- Liverpool University Dental Hospital
- Oregon Health and Science University
- University of Cambridge
- Imperial College London
- University of Liverpool
Research output: Contribution to journal › Article (journal) › peer-review
21
Link opens in a new tab
Citations
(Scopus)